株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の陽子線治療市場の将来動向

Global Proton Therapy Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 316436
出版日 ページ情報 英文 63 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
世界の陽子線治療市場の将来動向 Global Proton Therapy Market 2014-2018
出版日: 2014年10月15日 ページ情報: 英文 63 Pages
概要

陽子線治療とは、がん患者に陽子線を照射するという粒子線療法の一種です。陽子線治療の主な利点は、標的となる腫瘍細胞を破壊しつつも、周囲の細胞へのダメージは最小する、と言う点です。陽子線治療は細胞増殖を阻害するためにイオン化の手法を用います。陽子は体内を緩やかに移動し、電子と反応してエネルギーを発散します。MD Anderson Proton Therapy Centerがこの技術の先駆者で、同時にペンシルビーム陽子線治療(走査線治療・強度変調陽子線治療)の開発も主導してきました。世界の陽子線治療市場の2013〜2018年の年平均成長率(CAGR)は9.50%に達する、と予測されています。

当レポートでは、全世界の陽子線治療市場について分析し、陽子線治療の特徴や市場の構造、市場規模の動向(今後5年間の予測値)、地域別の詳細動向、市場の促進・抑制要因とその影響力、関連制度の整備状況、主要企業のプロファイル、今後の市場機会などを調査・考察しております。

第1章 エグゼクティブ・サマリー

第2章 略語集

第3章 分析範囲

  • 市場概要
  • 主な製品・サービス

第4章 市場分析の手法

  • 市場分析のプロセス
  • 分析手法

第5章 イントロダクション

第6章 市場環境

  • 市場概況
  • 市場規模とその予測
  • ファイブフォース分析

第7章 陽子線治療の重要性

第8章 陽子線治療センターの一覧

第9章 医療費償還シナリオ

第10章 地域別の分析

第11章 購入基準

第12章 市場の成長促進要因

第13章 促進要因とその影響力

第14章 市場の課題

第15章 促進要因・課題の影響力

第16章 市場の傾向

第17章 市場動向とその影響

第18章 ベンダー環境

  • 競争シナリオ
    • 近年の主な動向
    • 企業合併・買収(M&A)
  • 市場シェア分析
  • その他の著名なベンダー

第19章 主要ベンダーの分析

  • 日立製作所
    • 主要データ
    • 事業概要
    • 事業分類
    • 部門別の市場収益額(最新値)
    • 部門別の市場収益額(前年度との比較)
    • 地域別の市場収益額
    • 事業戦略
    • SWOT分析
  • IBA Proton Therapy
  • 三菱電機
  • Varian Medical Systems

第20章 その他の関連分析

図表一覧

目次
Product Code: IRTNTR4300

About Proton Therapy

Proton therapy is a type of particle therapy which is used to treat cancer patients by means of proton beams irradiation. The main advantage of proton therapy is that while destroying the target malignant cells, it causes minimal damage to the surrounding cells. Proton therapy uses the ionization technique to inhibit cell proliferation. Protons move slowly through the body and interact with electrons and discharge energy. The MD Anderson Proton Therapy Center is the pioneer in this technology and also initiated the pencil beam proton therapy, which is also known as scanning beam and intensity modulated proton therapy.

TechNavio's analysts forecast the Global Proton Therapy market to grow at a CAGR of 9.50 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Proton Therapy market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various products used for the treatment of cancer using the proton beam therapy.

TechNavio's report, Global Proton Therapy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Global Proton Therapy market landscape and its growth prospects in the coming years in the Americas, and the EMEA and APAC regions. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Hitachi
  • IBA Proton Therapy
  • Mitsubishi Electric
  • Varian Medical Systems

Other Prominent Vendors

  • Accuray
  • Advanced Oncotherapy
  • Advanced Particle Therapy
  • Advanced Proton Solutions
  • Best Particle Therapy
  • Compact Particle Acceleration
  • Elekta
  • GE Healthcare
  • Mevion Medical Systems
  • Optivus Proton Therapy
  • Procure Treatment Center
  • ProNova Solutions
  • ProTom International
  • SAH Global
  • Siemens
  • Sumitomo Heavy Industries
  • Toshiba

Market Driver

  • Technological Advancement

For a full, detailed list, view our report

Market Challenge

  • High Cost of Treatment

For a full, detailed list, view our report

Market Trend

  • Rise in Demand

For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Significance of Proton Therapy

08. List of Proton Therapy Centers

09. Reimbursement Scenario

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

  • 18.1. Competitive Scenario
    • 18.1.1. Key News
    • 18.1.2. Mergers and Acquisitions
  • 18.2. Market Share Analysis 2013
  • 18.3. Other Prominent Vendors

19. Key Vendor Analysis

  • 19.1. Hitachi
    • 19.1.1. Key Facts
    • 19.1.2. Business Overview
    • 19.1.3. Business Segmentation
    • 19.1.4. Business Segmentation by Revenue 2014
    • 19.1.5. Business Segmentation by Revenue 2013 and 2014
    • 19.1.6. Geographical Segmentation by Revenue 2014
    • 19.1.7. Business Strategy
    • 19.1.8. SWOT Analysis
  • 19.2. IBA Proton Therapy
    • 19.2.1. Key Facts
    • 19.2.2. Business Overview
    • 19.2.3. SWOT Analysis
  • 19.3. Mitsubishi Electric
    • 19.3.1. Key Facts
    • 19.3.2. Business Overview
    • 19.3.3. Business Segmentation by Revenue 2013
    • 19.3.4. Business Segmentation by Revenue 2012 and 2013
    • 19.3.5. Geographical Segmentation by Revenue 2013
    • 19.3.6. Business Strategy
    • 19.3.7. Recent Developments
    • 19.3.8. SWOT Analysis
  • 19.4. Varian Medical Systems
    • 19.4.1. Key Facts
    • 19.4.2. Business Description
    • 19.4.3. Business Segmentation
    • 19.4.4. Revenue Segmentation by Business
    • 19.4.5. Segmental Revenue Comparison - 2013 and 2012
    • 19.4.6. Sales by Geographical Segmentation
    • 19.4.7. Business Strategy
    • 19.4.8. Key Developments
    • 19.4.9. SWOT Analysis

20. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Proton Therapy Market 2013-2018 (US$ million)
  • Exhibit 3: Dose Determination in Proton Therapy: Bragg Peak
  • Exhibit 4: Proton Deposition Curve
  • Exhibit 5: List of Proton Therapy Centers in the US 2013
  • Exhibit 6: List of Proton Therapy Centers with IBA 2013
  • Exhibit 7: Comparison of the Number of Proton Therapy Centers and the Patient Base Being Served Globally
  • Exhibit 8: Current and Expected Number of Proton Therapy Rooms Globally
  • Exhibit 9: Global Proton Therapy Market by Geography Segmentation 2013
  • Exhibit 10: Global Proton Therapy Market Share Analysis 2018
  • Exhibit 11: Comparison of the Operational and Ordered Proton Therapy Systems of the Major Vendors
  • Exhibit 12: Comparison of the Patient Base Served by Vendors 2013
  • Exhibit 13: Number of Patients Treated by IBA Proton Therapy 2012 - 2015 (Expected)
  • Exhibit 14: Sales Comparison of IBA's Proton Therapy System 2007-2013 (US$ million)
  • Exhibit 15: Hitachi: Business Segmentation 2014
  • Exhibit 16: Hitachi: Business Segmentation by Revenue 2014
  • Exhibit 17: Hitachi: Business Segmentation by Revenue 2013 and 2014 (US$ million)
  • Exhibit 18: Hitachi: Geographical Segmentation by Revenue 2014
  • Exhibit 19: Global Proton Therapy Market: Business Segmentation by Revenue 2013
  • Exhibit 20: Mitsubishi: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 21: Mitsubishi Electric: Geographical Segmentation by Revenue 2013
  • Exhibit 22: Business Segmentation of Varian Medical Systems Inc.
  • Exhibit 23: Revenue Segmentation of Varian Medical Systems Inc. (2013)
  • Exhibit 24: Revenue Comparison (US$ million)
  • Exhibit 25: Revenue Segmentation of Varian Medical Systems Inc. by Geography (2013)
Back to Top